K18 FutureIQ is the biology-first, biotechnology haircare brand's first foray into hair longevity, and this serum targets premature aging that manifests as thinning, shedding, graying and scalp aging. To shield and support the hair and scalp against everyday stressors, this hair longevity serum introduces new, proprietary MultiVital technology, which uses a multi-pathway system to address everything from oxidative defense and follicle anchoring to pigmentation and scalp resilience.
This lightweight and fast-absorbing serum, meant to be applied nightly to a damp or dry scalp, is clinically proven to deliver up to 19,000 more hairs, fewer grays, and improved scalp barrier. In the first month of use, 100% showed reduced hair fall. By month two, density and the scalp barrier improved significantly; beyond that, total revitalization and the visual transformation are apparent.
Longevity Hair Serums
K18 FutureIQ Helps to Reduce Shedding, Graying and Scalp Aging
Trend Themes
-
Hair Longevity Serums — Biotech-driven scalp treatments are reframing haircare around aging prevention, creating room for premium products that address density, pigmentation, shedding and barrier health together.
-
Multi-pathway Beauty — Formulas targeting several biological mechanisms at once reflect a shift toward systems-based personal care with potential to outperform single-benefit anti-aging products.
-
Clinical Scalp Care — Evidence-backed scalp solutions are elevating consumer expectations for measurable outcomes, opening space for beauty brands that blend dermatology, wellness and cosmetic performance.
Industry Implications
-
Haircare — The category is expanding beyond styling and repair into longevity-focused regimens that treat the scalp as the foundation for sustained hair quality.
-
Biotechnology — Proprietary ingredient platforms and biological pathway targeting are becoming differentiators for beauty companies seeking defensible, science-led product advantages.
-
Anti-aging Beauty — Age-related concerns such as thinning, graying and barrier decline are broadening the anti-aging market from skin-centric products into full-body longevity applications.